GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Net Margin %

Sinco Pharmaceutical Holdings (HKSE:06833) Net Margin % : 1.57% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Sinco Pharmaceutical Holdings's Net Income for the six months ended in Dec. 2023 was HK$25 Mil. Sinco Pharmaceutical Holdings's Revenue for the six months ended in Dec. 2023 was HK$1,586 Mil. Therefore, Sinco Pharmaceutical Holdings's net margin for the quarter that ended in Dec. 2023 was 1.57%.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Net Margin % or its related term are showing as below:

HKSE:06833' s Net Margin % Range Over the Past 10 Years
Min: -29.45   Med: 2.66   Max: 7.3
Current: 1.67


HKSE:06833's Net Margin % is ranked better than
55.1% of 98 companies
in the Medical Distribution industry
Industry Median: 1.235 vs HKSE:06833: 1.67

Sinco Pharmaceutical Holdings Net Margin % Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Net Margin % Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 5.76 6.67 3.06 1.67

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.08 5.48 0.66 1.80 1.57

Competitive Comparison of Sinco Pharmaceutical Holdings's Net Margin %

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's Net Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Net Margin % falls into.



Sinco Pharmaceutical Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sinco Pharmaceutical Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=46.324/2778.267
=1.67 %

Sinco Pharmaceutical Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=24.891/1585.91
=1.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinco Pharmaceutical Holdings  (HKSE:06833) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sinco Pharmaceutical Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines